Member-only story
FDA Declares Common Cold Decongestants Ineffective: Expert Insights
A Physician’s Long-Held Concerns
Today, a panel of FDA experts has determined that most common cold decongestants are not helpful or ineffective.
In my professional practice as a general practitioner for more than 30 years, I have been clear about this for many years.
In addition, these products can be dangerous for some patients with heart problems, such as arrhythmias, heart failure, or hypertension.
They also have a rebound effect since when they are used; the patient notices that he needs more and more doses to achieve that minimum partial effect.
Suppose the FDA finally removes them from the market. In that case, pharmaceutical companies will lose a high source of income since these are over-the-counter drugs that do not need a prescription and are sold in large quantities in drug stores all day.
Specialized agencies have calculated that it represents:
The United States ‘ over-the-counter (OTC) drugs market size reached US$ 24.2 Billion in 2022.
And the 2023–2027 estimates:
The Decongestants Market size is estimated to reach $21.3 billion by 2027, growing at an estimated CAGR of 6.3% during the forecast…
